HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin Susmita Roy8 Jun 2022 10:34 AM GMTNew Delhi: In a major relief to pharmaceuticals major Boehringer Ingelheim, the High Court has restrained four domestic pharma companies namely, Eris...
Eli Lilly sued by whistleblower over drug manufacturing problems Ruchika Sharma8 Jun 2022 9:57 AM GMTThe company also said it "continues to cooperate" with a Justice Department subpoena and to work collaboratively with the U.S. Food and Drug...
Metformin improves antibacterial treatment speed and effectiveness, report researchers Dr. Kamal Kant Kohli29 May 2022 2:15 PM GMTOld dogs may not learn new tricks, but old drugs can, according to a research team based in China. The collaboration found that Metformin, a small...
Top Medical Bulletin 27/May/2022 Dr. Nandita Mohan27 May 2022 12:30 PM GMTHere are the top medical stories for today: Long-term breastfeeding protects against childhood asthma A cohort study results published in Annals of...
Add on metformin to standard breast cancer treatments fails to improve outcomes Dr. Kamal Kant Kohli26 May 2022 1:45 AM GMTA widely used and inexpensive Type 2 diabetes drug, once hoped to hold enormous promise in treating breast cancer, does not prevent or stop the spread...
Boehringer operating income edges up on Jardiance, animal health Ruchika Sharma6 April 2022 3:30 AM GMTFrankfurt: Germany's unlisted Boehringer Ingelheim said operating income rose 1.8% in 2021, driven by more prescriptions of diabetes drug Jardiance...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 5:54 AM GMTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novel drug Dorzagliatin may help diabetes patients achieve remission: Dream study Dr Kartikeya Kohli28 Sep 2021 5:30 AM GMTShanghai - Dorzagliatin, a glucokinase activator and a first-in-class investigational drug may make progress in diabetes remission finds a clinical...
Lupin to pay Rs 1824 crore to settle diabetes drug Glumetza suit in US Medical Dialogues Team23 Sep 2021 10:11 AM GMTNew Delhi: In an out-of-court settlement, Indian generic drug maker Lupin Pharmaceuticals Inc has decided to pay the Direct Purchaser Group Rs 1,103...
Metformin may be potential treatment for pre-eclampsia, finds BMJ study Dr Kartikeya Kohli23 Sep 2021 6:20 AM GMTMetformin may be potential treatment for pre-eclampsia, finds a new study. Metformin administration to women diagnosed with preterm pre-eclampsia may...
Diabetes drug lowers glaucoma risk along with blood sugar control in diabetics: Study Hina Zahid22 Sep 2021 3:45 AM GMTPHILADELPHIA - Glucagon-like peptide-1 receptor (GLP-1R) agonists is a popular class of diabetes medications that regulate blood sugar and are...
GLP1RAs associated with reduced amputation rate and CV risk in diabetics: Study Medha Baranwal15 Sep 2021 3:30 AM GMTTreatment with GLP1RAs, when compared with DPP4is, was associated with significantly lower composite adverse cardiovascular outcomes and major adverse...
